David Arciniegas
Concepts (420)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries | 40 | 2023 | 506 | 6.860 |
Why?
| | Brain Injuries, Traumatic | 17 | 2026 | 451 | 3.590 |
Why?
| | Cognition Disorders | 28 | 2016 | 539 | 3.320 |
Why?
| | Memory Disorders | 8 | 2024 | 196 | 2.120 |
Why?
| | Neuropsychological Tests | 32 | 2024 | 1134 | 2.010 |
Why?
| | Neuropsychiatry | 6 | 2020 | 17 | 1.860 |
Why?
| | Bipolar Disorder | 11 | 2023 | 278 | 1.810 |
Why?
| | Cholinesterase Inhibitors | 5 | 2024 | 47 | 1.670 |
Why?
| | Neurosciences | 3 | 2017 | 23 | 1.370 |
Why?
| | Indans | 2 | 2024 | 13 | 1.250 |
Why?
| | Mental Disorders | 18 | 2014 | 1154 | 1.230 |
Why?
| | Methylphenidate | 5 | 2025 | 49 | 1.190 |
Why?
| | Piperidines | 2 | 2024 | 219 | 1.100 |
Why?
| | Central Nervous System Stimulants | 5 | 2025 | 185 | 1.060 |
Why?
| | Physical and Rehabilitation Medicine | 2 | 2025 | 30 | 1.040 |
Why?
| | Crying | 6 | 2014 | 15 | 1.020 |
Why?
| | Mood Disorders | 6 | 2023 | 140 | 0.970 |
Why?
| | Consciousness Disorders | 5 | 2023 | 25 | 0.970 |
Why?
| | Affective Symptoms | 5 | 2014 | 53 | 0.920 |
Why?
| | Brain | 21 | 2023 | 2934 | 0.920 |
Why?
| | Nootropic Agents | 1 | 2024 | 30 | 0.860 |
Why?
| | Frontotemporal Dementia | 2 | 2023 | 57 | 0.860 |
Why?
| | Aggression | 4 | 2014 | 178 | 0.860 |
Why?
| | Laughter | 5 | 2014 | 8 | 0.840 |
Why?
| | Psychotic Disorders | 5 | 2015 | 185 | 0.820 |
Why?
| | Consciousness | 1 | 2023 | 34 | 0.790 |
Why?
| | Hypoxia-Ischemia, Brain | 3 | 2010 | 48 | 0.790 |
Why?
| | Receptors, Cholinergic | 4 | 2011 | 41 | 0.760 |
Why?
| | Nervous System Diseases | 7 | 2020 | 285 | 0.760 |
Why?
| | Aphasia | 3 | 2026 | 24 | 0.750 |
Why?
| | Memory | 7 | 2024 | 296 | 0.740 |
Why?
| | Humans | 129 | 2026 | 144667 | 0.730 |
Why?
| | Lupus Erythematosus, Systemic | 8 | 2013 | 238 | 0.720 |
Why?
| | Evoked Potentials, Auditory | 6 | 2004 | 180 | 0.680 |
Why?
| | Forensic Psychiatry | 2 | 2013 | 29 | 0.660 |
Why?
| | Psychiatry | 4 | 2016 | 196 | 0.650 |
Why?
| | Irritable Mood | 3 | 2022 | 50 | 0.610 |
Why?
| | Functional Laterality | 8 | 2016 | 241 | 0.610 |
Why?
| | Antipsychotic Agents | 4 | 2015 | 214 | 0.600 |
Why?
| | Psychomotor Performance | 5 | 2011 | 328 | 0.580 |
Why?
| | Diagnosis, Differential | 16 | 2017 | 1501 | 0.580 |
Why?
| | Hallucinations | 2 | 2016 | 31 | 0.580 |
Why?
| | Alcoholism | 6 | 2022 | 813 | 0.580 |
Why?
| | Adult | 53 | 2026 | 40489 | 0.570 |
Why?
| | Hippocampus | 9 | 2019 | 966 | 0.570 |
Why?
| | Psychiatric Status Rating Scales | 10 | 2015 | 539 | 0.570 |
Why?
| | Amnesia | 3 | 2023 | 47 | 0.570 |
Why?
| | Acetylcholine | 4 | 2011 | 208 | 0.560 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 410 | 0.550 |
Why?
| | Brain Injury, Chronic | 2 | 2013 | 25 | 0.540 |
Why?
| | Confusion | 2 | 2020 | 30 | 0.540 |
Why?
| | Cholinergic Fibers | 3 | 2011 | 19 | 0.530 |
Why?
| | Diffusion Tensor Imaging | 2 | 2024 | 75 | 0.520 |
Why?
| | Severity of Illness Index | 12 | 2011 | 2922 | 0.510 |
Why?
| | Neurology | 2 | 2010 | 114 | 0.500 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 3 | 2014 | 232 | 0.490 |
Why?
| | Cognition | 7 | 2018 | 1263 | 0.480 |
Why?
| | Attention | 9 | 2019 | 458 | 0.480 |
Why?
| | Capgras Syndrome | 1 | 2016 | 3 | 0.470 |
Why?
| | Politics | 1 | 2017 | 95 | 0.470 |
Why?
| | Dementia | 3 | 2013 | 319 | 0.470 |
Why?
| | West Nile Fever | 2 | 2008 | 57 | 0.460 |
Why?
| | Impulsive Behavior | 2 | 2014 | 143 | 0.460 |
Why?
| | Expert Testimony | 2 | 2013 | 42 | 0.450 |
Why?
| | Dopamine Agents | 2 | 2006 | 22 | 0.450 |
Why?
| | Pseudobulbar Palsy | 2 | 2005 | 2 | 0.450 |
Why?
| | Journalism, Medical | 1 | 2015 | 4 | 0.440 |
Why?
| | Male | 65 | 2026 | 72431 | 0.440 |
Why?
| | Stroke Rehabilitation | 2 | 2005 | 43 | 0.440 |
Why?
| | Brain Concussion | 5 | 2023 | 640 | 0.430 |
Why?
| | Connectome | 3 | 2023 | 93 | 0.430 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2015 | 56 | 0.420 |
Why?
| | Middle Aged | 40 | 2026 | 35971 | 0.400 |
Why?
| | Double-Blind Method | 6 | 2024 | 2033 | 0.390 |
Why?
| | Recovery of Function | 5 | 2019 | 715 | 0.390 |
Why?
| | Psychotropic Drugs | 1 | 2014 | 77 | 0.390 |
Why?
| | Periodicals as Topic | 1 | 2016 | 206 | 0.380 |
Why?
| | Neurotransmitter Agents | 3 | 2008 | 83 | 0.380 |
Why?
| | Mental Status Schedule | 2 | 2010 | 35 | 0.380 |
Why?
| | Behavioral Symptoms | 1 | 2013 | 41 | 0.370 |
Why?
| | Football | 1 | 2013 | 89 | 0.360 |
Why?
| | Electroencephalography | 4 | 2015 | 555 | 0.360 |
Why?
| | Phenylcarbamates | 2 | 2009 | 4 | 0.360 |
Why?
| | Schizophrenia | 4 | 2015 | 443 | 0.350 |
Why?
| | Magnetic Resonance Imaging | 19 | 2023 | 3888 | 0.340 |
Why?
| | Treatment Outcome | 14 | 2024 | 11735 | 0.340 |
Why?
| | Veterans | 4 | 2023 | 1614 | 0.320 |
Why?
| | Neuroprotective Agents | 2 | 2009 | 145 | 0.320 |
Why?
| | Frontal Lobe | 3 | 2013 | 159 | 0.320 |
Why?
| | Female | 49 | 2026 | 78304 | 0.310 |
Why?
| | Capital Punishment | 1 | 2010 | 4 | 0.310 |
Why?
| | Surveys and Questionnaires | 5 | 2023 | 6041 | 0.300 |
Why?
| | Delirium | 2 | 2024 | 105 | 0.300 |
Why?
| | Cerebral Cortex | 5 | 2019 | 470 | 0.300 |
Why?
| | Public Policy | 1 | 2010 | 79 | 0.300 |
Why?
| | Violence | 1 | 2013 | 279 | 0.300 |
Why?
| | Post-Concussion Syndrome | 3 | 2013 | 184 | 0.290 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 2 | 2015 | 104 | 0.290 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2010 | 99 | 0.280 |
Why?
| | Reflex | 1 | 2009 | 70 | 0.280 |
Why?
| | White Matter | 2 | 2024 | 153 | 0.270 |
Why?
| | Insanity Defense | 1 | 2008 | 11 | 0.270 |
Why?
| | Neuroanatomy | 2 | 2023 | 10 | 0.270 |
Why?
| | Geriatric Assessment | 1 | 2010 | 233 | 0.270 |
Why?
| | Amygdala | 3 | 2018 | 198 | 0.270 |
Why?
| | Dibenzothiazepines | 1 | 2007 | 18 | 0.270 |
Why?
| | Crime | 1 | 2008 | 59 | 0.260 |
Why?
| | Injury Severity Score | 5 | 2019 | 602 | 0.260 |
Why?
| | Rivastigmine | 3 | 2021 | 6 | 0.260 |
Why?
| | Alzheimer Disease | 3 | 2011 | 622 | 0.250 |
Why?
| | Stroke | 5 | 2015 | 1262 | 0.250 |
Why?
| | Depression | 4 | 2009 | 1561 | 0.240 |
Why?
| | Affect | 4 | 2008 | 322 | 0.240 |
Why?
| | Cognitive Dysfunction | 2 | 2024 | 464 | 0.240 |
Why?
| | Executive Function | 2 | 2016 | 460 | 0.240 |
Why?
| | Hiccup | 1 | 2006 | 2 | 0.240 |
Why?
| | Adrenergic Agents | 1 | 2006 | 7 | 0.240 |
Why?
| | Behavioral Sciences | 1 | 2006 | 8 | 0.240 |
Why?
| | Aged | 16 | 2024 | 25955 | 0.230 |
Why?
| | Hemiplegia | 1 | 2005 | 20 | 0.230 |
Why?
| | Clinical Trials as Topic | 2 | 2009 | 1056 | 0.230 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 589 | 0.230 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2025 | 59 | 0.230 |
Why?
| | Indians, North American | 2 | 2010 | 597 | 0.230 |
Why?
| | Neuropsychology | 1 | 2006 | 42 | 0.220 |
Why?
| | Paresis | 1 | 2005 | 30 | 0.220 |
Why?
| | Military Personnel | 2 | 2023 | 733 | 0.220 |
Why?
| | Amantadine | 1 | 2004 | 8 | 0.220 |
Why?
| | Suicide | 1 | 2013 | 725 | 0.220 |
Why?
| | Physical Therapy Modalities | 2 | 2005 | 334 | 0.220 |
Why?
| | Psychosurgery | 1 | 2004 | 9 | 0.220 |
Why?
| | Specialization | 1 | 2006 | 136 | 0.220 |
Why?
| | Neurologic Examination | 5 | 2008 | 132 | 0.210 |
Why?
| | Encephalitis, Herpes Simplex | 1 | 2004 | 21 | 0.210 |
Why?
| | Motor Skills | 1 | 2005 | 104 | 0.210 |
Why?
| | Upper Extremity | 1 | 2005 | 113 | 0.210 |
Why?
| | Disability Evaluation | 3 | 2019 | 310 | 0.210 |
Why?
| | Mental Competency | 1 | 2024 | 26 | 0.210 |
Why?
| | Neuroimaging | 5 | 2019 | 293 | 0.200 |
Why?
| | Healthy Aging | 1 | 2024 | 40 | 0.200 |
Why?
| | Stress Disorders, Post-Traumatic | 4 | 2021 | 889 | 0.200 |
Why?
| | Comorbidity | 3 | 2014 | 1652 | 0.200 |
Why?
| | Hospital Mortality | 1 | 2008 | 1033 | 0.200 |
Why?
| | Valproic Acid | 2 | 2022 | 48 | 0.190 |
Why?
| | Research Design | 1 | 2009 | 1129 | 0.180 |
Why?
| | Analysis of Variance | 5 | 2007 | 1301 | 0.180 |
Why?
| | Critical Care | 1 | 2008 | 695 | 0.180 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 2117 | 0.180 |
Why?
| | Delusions | 2 | 2015 | 9 | 0.180 |
Why?
| | Myelin Sheath | 1 | 2024 | 169 | 0.180 |
Why?
| | Magnetoencephalography | 5 | 2011 | 161 | 0.170 |
Why?
| | Regression Analysis | 5 | 2013 | 998 | 0.170 |
Why?
| | Emotions | 3 | 2019 | 578 | 0.170 |
Why?
| | Dominance, Cerebral | 1 | 2000 | 56 | 0.160 |
Why?
| | Thalamus | 2 | 2018 | 127 | 0.160 |
Why?
| | Central Nervous System Agents | 1 | 2000 | 7 | 0.160 |
Why?
| | Young Adult | 8 | 2026 | 14122 | 0.160 |
Why?
| | Exercise Therapy | 1 | 2005 | 475 | 0.160 |
Why?
| | Electroconvulsive Therapy | 2 | 2014 | 15 | 0.160 |
Why?
| | Mental Status and Dementia Tests | 1 | 2020 | 26 | 0.160 |
Why?
| | United States | 8 | 2025 | 16018 | 0.160 |
Why?
| | Conversion Disorder | 1 | 2020 | 10 | 0.150 |
Why?
| | Rehabilitation Centers | 1 | 2020 | 39 | 0.150 |
Why?
| | Acceptance and Commitment Therapy | 1 | 2020 | 31 | 0.150 |
Why?
| | Prisoners | 1 | 2021 | 143 | 0.150 |
Why?
| | Brain Diseases | 1 | 2000 | 152 | 0.150 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.150 |
Why?
| | Adult Survivors of Child Adverse Events | 1 | 2019 | 15 | 0.150 |
Why?
| | Sensory Thresholds | 1 | 1999 | 31 | 0.140 |
Why?
| | Glasgow Coma Scale | 2 | 2011 | 218 | 0.140 |
Why?
| | Habenula | 1 | 2018 | 13 | 0.140 |
Why?
| | Terminology as Topic | 3 | 2025 | 255 | 0.140 |
Why?
| | Facial Expression | 1 | 2019 | 73 | 0.140 |
Why?
| | Lithium Compounds | 1 | 2018 | 11 | 0.140 |
Why?
| | Hospitalization | 1 | 2008 | 2446 | 0.130 |
Why?
| | Sertraline | 2 | 2009 | 27 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2013 | 625 | 0.130 |
Why?
| | Spatial Memory | 1 | 2017 | 28 | 0.130 |
Why?
| | Substance-Related Disorders | 2 | 2020 | 1090 | 0.130 |
Why?
| | Prospective Studies | 6 | 2017 | 7994 | 0.130 |
Why?
| | Inpatients | 3 | 2026 | 547 | 0.130 |
Why?
| | Suicidal Ideation | 2 | 2023 | 575 | 0.130 |
Why?
| | Anxiety Disorders | 2 | 2014 | 370 | 0.120 |
Why?
| | Factor Analysis, Statistical | 1 | 2017 | 290 | 0.120 |
Why?
| | Glutamic Acid | 2 | 2011 | 254 | 0.120 |
Why?
| | Choline | 4 | 2013 | 136 | 0.120 |
Why?
| | Biomechanical Phenomena | 2 | 2011 | 852 | 0.120 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2016 | 21 | 0.120 |
Why?
| | Encephalitis | 1 | 2017 | 142 | 0.120 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3414 | 0.110 |
Why?
| | Evidence-Based Medicine | 2 | 2011 | 732 | 0.110 |
Why?
| | Aged, 80 and over | 4 | 2011 | 8284 | 0.110 |
Why?
| | Prognosis | 4 | 2019 | 4312 | 0.110 |
Why?
| | Aspartic Acid | 3 | 2011 | 87 | 0.110 |
Why?
| | Suicide, Attempted | 1 | 2018 | 421 | 0.110 |
Why?
| | Retrospective Studies | 8 | 2026 | 17149 | 0.100 |
Why?
| | Behavior, Animal | 1 | 2017 | 521 | 0.100 |
Why?
| | Case-Control Studies | 5 | 2011 | 3603 | 0.100 |
Why?
| | Creatine | 2 | 2011 | 63 | 0.100 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2015 | 154 | 0.100 |
Why?
| | Incidence | 3 | 2026 | 2892 | 0.100 |
Why?
| | Leukoencephalopathies | 1 | 2013 | 24 | 0.100 |
Why?
| | Volition | 2 | 2006 | 34 | 0.100 |
Why?
| | Length of Stay | 2 | 2011 | 1339 | 0.100 |
Why?
| | Range of Motion, Articular | 2 | 2005 | 423 | 0.090 |
Why?
| | Hyperbaric Oxygenation | 1 | 2012 | 39 | 0.090 |
Why?
| | Blast Injuries | 1 | 2012 | 62 | 0.090 |
Why?
| | Neurobiology | 1 | 2011 | 14 | 0.080 |
Why?
| | Forensic Medicine | 1 | 2011 | 17 | 0.080 |
Why?
| | Phenotype | 1 | 1999 | 3147 | 0.080 |
Why?
| | Referral and Consultation | 3 | 2024 | 852 | 0.080 |
Why?
| | Trauma Severity Indices | 1 | 2011 | 115 | 0.080 |
Why?
| | Schizophrenic Psychology | 2 | 2002 | 97 | 0.080 |
Why?
| | Multiple Sclerosis | 2 | 2007 | 485 | 0.080 |
Why?
| | Rest | 1 | 2011 | 123 | 0.080 |
Why?
| | Cohort Studies | 4 | 2023 | 5957 | 0.080 |
Why?
| | Antidepressive Agents | 2 | 2018 | 248 | 0.080 |
Why?
| | Risk Assessment | 3 | 2011 | 3729 | 0.080 |
Why?
| | Economics | 1 | 2010 | 10 | 0.080 |
Why?
| | Supreme Court Decisions | 1 | 2010 | 12 | 0.080 |
Why?
| | Delphi Technique | 2 | 2023 | 330 | 0.080 |
Why?
| | Language Disorders | 1 | 2010 | 29 | 0.080 |
Why?
| | Anxiety | 1 | 2017 | 1122 | 0.080 |
Why?
| | Consensus | 2 | 2023 | 475 | 0.080 |
Why?
| | Evoked Potentials, Somatosensory | 2 | 1999 | 39 | 0.070 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2009 | 31 | 0.070 |
Why?
| | Citalopram | 1 | 2009 | 32 | 0.070 |
Why?
| | Capsules | 1 | 2009 | 42 | 0.070 |
Why?
| | Atrophy | 2 | 2007 | 199 | 0.070 |
Why?
| | International Classification of Diseases | 1 | 2010 | 147 | 0.070 |
Why?
| | Time | 1 | 2009 | 86 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2014 | 771 | 0.070 |
Why?
| | Adolescent | 6 | 2019 | 22409 | 0.070 |
Why?
| | Neurochemistry | 1 | 2008 | 5 | 0.070 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 229 | 0.070 |
Why?
| | Animals | 7 | 2017 | 37948 | 0.070 |
Why?
| | Medical Records | 1 | 2009 | 191 | 0.070 |
Why?
| | Antibodies | 1 | 2010 | 396 | 0.070 |
Why?
| | Presenilin-2 | 1 | 2007 | 6 | 0.070 |
Why?
| | Quetiapine Fumarate | 1 | 2007 | 26 | 0.070 |
Why?
| | Dissociative Disorders | 1 | 2008 | 30 | 0.070 |
Why?
| | Presenilin-1 | 1 | 2007 | 32 | 0.070 |
Why?
| | Research | 1 | 2011 | 431 | 0.060 |
Why?
| | Interpersonal Relations | 1 | 2010 | 399 | 0.060 |
Why?
| | Receptors, Neurotransmitter | 1 | 2007 | 20 | 0.060 |
Why?
| | Prevalence | 2 | 2021 | 2839 | 0.060 |
Why?
| | Motor Activity | 2 | 2017 | 723 | 0.060 |
Why?
| | Wasting Disease, Chronic | 1 | 2007 | 26 | 0.060 |
Why?
| | Intelligence Tests | 1 | 2007 | 55 | 0.060 |
Why?
| | Neurosecretory Systems | 1 | 2007 | 31 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 3 | 2019 | 2754 | 0.060 |
Why?
| | Drug Administration Schedule | 1 | 2009 | 779 | 0.060 |
Why?
| | Pituitary ACTH Hypersecretion | 1 | 2006 | 12 | 0.060 |
Why?
| | Expressed Emotion | 1 | 2006 | 15 | 0.060 |
Why?
| | Gyrus Cinguli | 2 | 2023 | 96 | 0.060 |
Why?
| | Disease Management | 1 | 2010 | 650 | 0.060 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1995 | 0.060 |
Why?
| | Pilot Projects | 2 | 2010 | 1886 | 0.060 |
Why?
| | Lithium Carbonate | 1 | 2006 | 6 | 0.060 |
Why?
| | Biogenic Amines | 1 | 2006 | 4 | 0.060 |
Why?
| | Accidents, Traffic | 1 | 2007 | 193 | 0.060 |
Why?
| | Language Tests | 1 | 2026 | 23 | 0.060 |
Why?
| | Demography | 1 | 2007 | 287 | 0.060 |
Why?
| | Neurological Rehabilitation | 1 | 2026 | 12 | 0.060 |
Why?
| | Illusions | 1 | 2006 | 15 | 0.060 |
Why?
| | Medical History Taking | 1 | 2006 | 117 | 0.060 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2025 | 6 | 0.060 |
Why?
| | Sex Factors | 2 | 2003 | 2104 | 0.060 |
Why?
| | Education | 1 | 2006 | 105 | 0.060 |
Why?
| | Disease Progression | 2 | 2011 | 2847 | 0.060 |
Why?
| | Age Factors | 2 | 2019 | 3329 | 0.060 |
Why?
| | Restraint, Physical | 1 | 2005 | 75 | 0.060 |
Why?
| | Norepinephrine | 1 | 2025 | 196 | 0.050 |
Why?
| | Health Surveys | 1 | 2007 | 517 | 0.050 |
Why?
| | Diazepam | 1 | 2004 | 33 | 0.050 |
Why?
| | Confidence Intervals | 1 | 2005 | 331 | 0.050 |
Why?
| | History, Ancient | 1 | 2004 | 55 | 0.050 |
Why?
| | History, 19th Century | 1 | 2004 | 63 | 0.050 |
Why?
| | Probability | 1 | 2005 | 309 | 0.050 |
Why?
| | Patient Selection | 1 | 2009 | 727 | 0.050 |
Why?
| | Arm | 1 | 2005 | 110 | 0.050 |
Why?
| | Benzodiazepines | 1 | 2006 | 168 | 0.050 |
Why?
| | Narcotics | 1 | 2004 | 58 | 0.050 |
Why?
| | Hydrocortisone | 1 | 2006 | 297 | 0.050 |
Why?
| | Psychological Tests | 1 | 2005 | 132 | 0.050 |
Why?
| | Demyelinating Diseases | 1 | 2004 | 84 | 0.050 |
Why?
| | Physostigmine | 1 | 2004 | 13 | 0.050 |
Why?
| | Cognitive Aging | 1 | 2024 | 18 | 0.050 |
Why?
| | Age of Onset | 1 | 2006 | 551 | 0.050 |
Why?
| | Autoantibodies | 1 | 2011 | 1505 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2024 | 72 | 0.050 |
Why?
| | Cytokines | 1 | 2011 | 2045 | 0.050 |
Why?
| | Nerve Net | 1 | 2007 | 284 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2005 | 177 | 0.050 |
Why?
| | North America | 1 | 2004 | 312 | 0.050 |
Why?
| | Time Factors | 2 | 2007 | 7140 | 0.050 |
Why?
| | History, 20th Century | 1 | 2004 | 327 | 0.050 |
Why?
| | Electrophysiology | 1 | 2003 | 218 | 0.050 |
Why?
| | Akinetic Mutism | 1 | 2003 | 3 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2023 | 2942 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2023 | 119 | 0.050 |
Why?
| | Methadone | 1 | 2004 | 122 | 0.050 |
Why?
| | Cooperative Behavior | 2 | 2006 | 464 | 0.050 |
Why?
| | Cerebral Arterial Diseases | 1 | 2003 | 49 | 0.050 |
Why?
| | Physician's Role | 1 | 2004 | 221 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2005 | 242 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2004 | 216 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 386 | 0.050 |
Why?
| | Auditory Cortex | 1 | 2002 | 46 | 0.050 |
Why?
| | Geriatric Psychiatry | 1 | 2002 | 11 | 0.040 |
Why?
| | Psychotherapy | 1 | 2003 | 190 | 0.040 |
Why?
| | Coronary Artery Bypass | 1 | 2004 | 267 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 355 | 0.040 |
Why?
| | Unconsciousness | 1 | 2001 | 22 | 0.040 |
Why?
| | Acute Disease | 1 | 2004 | 1029 | 0.040 |
Why?
| | Chronic Disease | 2 | 2005 | 1810 | 0.040 |
Why?
| | Health Services for the Aged | 1 | 2002 | 71 | 0.040 |
Why?
| | Transdermal Patch | 1 | 2021 | 15 | 0.040 |
Why?
| | Interviews as Topic | 1 | 2005 | 905 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2025 | 305 | 0.040 |
Why?
| | Myelinolysis, Central Pontine | 1 | 2000 | 3 | 0.040 |
Why?
| | Psychomotor Disorders | 1 | 2000 | 15 | 0.040 |
Why?
| | Disease Models, Animal | 1 | 2011 | 4539 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2005 | 607 | 0.040 |
Why?
| | Rehabilitation Research | 1 | 2020 | 7 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2870 | 0.040 |
Why?
| | Prefrontal Cortex | 1 | 2023 | 331 | 0.040 |
Why?
| | Societies, Medical | 2 | 2020 | 890 | 0.040 |
Why?
| | Treatment Failure | 1 | 2021 | 365 | 0.040 |
Why?
| | Epilepsies, Partial | 1 | 2000 | 63 | 0.040 |
Why?
| | Syndrome | 1 | 2000 | 379 | 0.040 |
Why?
| | Magnetics | 1 | 1999 | 47 | 0.040 |
Why?
| | Glasgow Outcome Scale | 1 | 2019 | 14 | 0.040 |
Why?
| | Happiness | 1 | 2019 | 23 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1268 | 0.040 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2000 | 151 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2020 | 132 | 0.040 |
Why?
| | Pituitary Gland | 1 | 1999 | 148 | 0.040 |
Why?
| | Corpus Striatum | 1 | 2000 | 179 | 0.040 |
Why?
| | Temporal Lobe | 1 | 2019 | 103 | 0.040 |
Why?
| | Curriculum | 1 | 2006 | 1063 | 0.030 |
Why?
| | Reference Values | 1 | 2000 | 794 | 0.030 |
Why?
| | Organ Size | 1 | 2019 | 461 | 0.030 |
Why?
| | Evoked Potentials | 1 | 2019 | 127 | 0.030 |
Why?
| | Reaction Time | 1 | 2000 | 438 | 0.030 |
Why?
| | Gliosis | 1 | 2017 | 29 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2018 | 5414 | 0.030 |
Why?
| | Maze Learning | 1 | 2017 | 105 | 0.030 |
Why?
| | Social Stigma | 1 | 2020 | 172 | 0.030 |
Why?
| | Coronary Artery Disease | 1 | 2004 | 743 | 0.030 |
Why?
| | Patient Discharge | 1 | 2024 | 985 | 0.030 |
Why?
| | Gray Matter | 1 | 2018 | 92 | 0.030 |
Why?
| | Brain Chemistry | 2 | 2009 | 116 | 0.030 |
Why?
| | Bayes Theorem | 1 | 2019 | 426 | 0.030 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 1999 | 286 | 0.030 |
Why?
| | Decision Making | 1 | 2024 | 973 | 0.030 |
Why?
| | Mass Screening | 1 | 2005 | 1348 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 393 | 0.030 |
Why?
| | Astrocytes | 1 | 2017 | 228 | 0.030 |
Why?
| | Fear | 1 | 2019 | 366 | 0.030 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2015 | 48 | 0.030 |
Why?
| | Microglia | 1 | 2017 | 269 | 0.030 |
Why?
| | Academic Medical Centers | 2 | 2010 | 545 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 845 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1136 | 0.030 |
Why?
| | Biomarkers | 2 | 2011 | 4261 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2011 | 1537 | 0.030 |
Why?
| | Software | 1 | 1999 | 695 | 0.030 |
Why?
| | Colorado | 3 | 2011 | 4558 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 343 | 0.020 |
Why?
| | Child | 2 | 2019 | 22600 | 0.020 |
Why?
| | Aging | 1 | 2024 | 1938 | 0.020 |
Why?
| | Risk Factors | 2 | 2004 | 10796 | 0.020 |
Why?
| | Creatinine | 1 | 2013 | 509 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2004 | 2950 | 0.020 |
Why?
| | Caregivers | 1 | 2020 | 1062 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 524 | 0.020 |
Why?
| | Memory, Short-Term | 1 | 2013 | 271 | 0.020 |
Why?
| | Visual Perception | 1 | 2011 | 182 | 0.020 |
Why?
| | Neurofibrillary Tangles | 1 | 2007 | 13 | 0.020 |
Why?
| | Brain Mapping | 1 | 2011 | 535 | 0.020 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2007 | 42 | 0.020 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2007 | 79 | 0.020 |
Why?
| | Axons | 1 | 2009 | 203 | 0.020 |
Why?
| | Pituitary Hormones, Anterior | 1 | 2007 | 7 | 0.020 |
Why?
| | Disease Reservoirs | 1 | 2007 | 25 | 0.020 |
Why?
| | Pituitary Gland, Anterior | 1 | 2007 | 37 | 0.020 |
Why?
| | Lupus Vasculitis, Central Nervous System | 1 | 2007 | 14 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2007 | 305 | 0.020 |
Why?
| | Prolactin | 1 | 2007 | 87 | 0.020 |
Why?
| | Point Mutation | 1 | 2007 | 242 | 0.020 |
Why?
| | Introns | 1 | 2007 | 255 | 0.020 |
Why?
| | Thyrotropin | 1 | 2007 | 119 | 0.020 |
Why?
| | Psychomotor Agitation | 1 | 2007 | 70 | 0.010 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2007 | 147 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5870 | 0.010 |
Why?
| | Antiemetics | 1 | 2006 | 48 | 0.010 |
Why?
| | Stereotyping | 1 | 2006 | 47 | 0.010 |
Why?
| | Vomiting | 1 | 2006 | 131 | 0.010 |
Why?
| | Benzamides | 1 | 2006 | 224 | 0.010 |
Why?
| | Verbal Behavior | 1 | 2005 | 43 | 0.010 |
Why?
| | Mental Processes | 1 | 2005 | 38 | 0.010 |
Why?
| | Skull | 1 | 2006 | 161 | 0.010 |
Why?
| | Carbamazepine | 1 | 2005 | 22 | 0.010 |
Why?
| | MEDLINE | 1 | 2005 | 20 | 0.010 |
Why?
| | Saliva | 1 | 2006 | 247 | 0.010 |
Why?
| | Mental Health Services | 1 | 2010 | 472 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2007 | 613 | 0.010 |
Why?
| | Central Nervous System Diseases | 1 | 2005 | 74 | 0.010 |
Why?
| | Central Nervous System | 1 | 2005 | 279 | 0.010 |
Why?
| | Hospitals, Veterans | 1 | 2004 | 258 | 0.010 |
Why?
| | Radiography | 1 | 2005 | 848 | 0.010 |
Why?
| | Language | 1 | 2005 | 323 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2019 | 0.010 |
Why?
| | Pain | 1 | 2007 | 785 | 0.010 |
Why?
| | Brain Ischemia | 1 | 2005 | 358 | 0.010 |
Why?
| | Mice | 1 | 2017 | 18261 | 0.010 |
Why?
| | Median Nerve | 1 | 1999 | 26 | 0.010 |
Why?
| | Electric Stimulation | 1 | 1999 | 277 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 1999 | 480 | 0.010 |
Why?
|
|
Arciniegas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|